Oboi Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.45 M
- Company Age 39 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -49.60%
- Profit Growth -73.10%
- Ebitda 13.85%
- Net Worth 3.17%
- Total Assets 3.54%
About Oboi Laboratories
Oboi Laboratories Pvt Ltd (OLPL) is a Private Limited Indian Non-Government Company incorporated in India on 08 July 1985 and has a history of 39 years and seven months. Its registered office is in Mumbai, Maharashtra.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.45 M, as per Ministry of Corporate Affairs (MCA) records.
Kirti Shah, Samir Shah, and Keyur Shah serve as directors at the Company.
Company Details
-
LocationMumbai, Maharashtra
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U99999MH1985PTC036765
-
Company No.
036765
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
08 Jul 1985
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Oboi Laboratories?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Samir Shah
|
Director | 01-Apr-2005 | Current |
|
Keyur Shah
|
Director | 21-Aug-2023 | Current |
|
Kirti Shah
|
Director | 01-Nov-1995 | Current |
Financial Performance of Oboi Laboratories.
Oboi Laboratories Pvt Ltd, for the financial year ended 2022, experienced significant reduction in revenue, with a 49.6% decrease. The company also saw a substantial fall in profitability, with a 73.1% decrease in profit. The company's net worth moved up by a moderate rise of 3.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Oboi Laboratories?
In 2019, Oboi Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Cho-Spn Lifescience And Research Private LimitedKirti Shah, Samir Shah and 1 more are mutual person
-
Ciron Drugs And Pharmaceuticals Private LimitedKirti Shah, Samir Shah and 1 more are mutual person
-
Acco Commercial LlpKirti Shah, Samir Shah and 1 more are mutual person
-
Anantya Technologies Llp
Samir Shah is a mutual person
-
Karuna Kui Foundation
Samir Shah is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Oboi Laboratories?
Unlock and access historical data on people associated with Oboi Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Oboi Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oboi Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
